CDSCO UID MFG/MD/2018/000029_fa75720deec106fe8716e80f840db4f7_48993743ea5e0a9e5d034f2689ad6f82Drug of Abuse Rapid Test- Barbiturate-300mg/ml
- UID
- MFG/MD/2018/000029_fa75720deec106fe8716e80f840db4f7_48993743ea5e0a9e5d034f2689ad6f82
- Device class
- Class C
- Brand name
- Merilisa
- License holder
- Meril Diagnostics Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- Drug of Abuse(Merilisa)Rapid Test Barbiturate-300mg/ml(Merilisa) is a qualitative immunoassay intended to be used to detect the presence of Barbiturate drugs and/or their metabolites at or above the specified cut of level in human urine in a single assay
Drug of Abuse Rapid Test- Barbiturate-300mg/ml is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000029_fa75720deec106fe8716e80f840db4f7_48993743ea5e0a9e5d034f2689ad6f82. This device is marketed under the brand name Merilisa. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.